Retinopathy of prematurity.

Area of Science:

• Ophthalmology
• Neonatology
• Pediatric Medicine

Background:

• Retinopathy of prematurity (ROP) is a vasoproliferative retinal disorder affecting premature and low birth weight infants.
• ROP presents in distinct stages (1-5) and zones (I-III), necessitating structured diagnostic and management protocols.
• Timely intervention is critical to prevent irreversible vision impairment.

Purpose of the Study:

• To provide a concise overview of Retinopathy of Prematurity (ROP) screening and management guidelines.
• To highlight the importance of early detection and treatment within 72 hours of threshold ROP diagnosis.
• To outline treatment modalities for different stages and zones of ROP, including specialized approaches for Rush disease.

Main Methods:

• Review of current screening protocols for ROP in premature infants.
• Description of treatment options: laser photocoagulation, cryotherapy, scleral buckling, and vitreoretinal surgery.
• Emphasis on the timing and urgency of treatment initiation upon threshold ROP detection.

Main Results:

• Screening guidelines for ROP (who, when, how) are essential for early detection.
• Threshold ROP requires treatment within 72 hours to prevent progression.
• Specific treatments vary by ROP stage and zone, with aggressive approaches for Zone I ROP (Rush disease) and surgical interventions for advanced stages (IVA, IVB, V).

Conclusions:

• Effective management of ROP hinges on timely screening and prompt treatment.
• Awareness and adherence to established protocols are vital for preventing blindness in affected infants.
• Multimodal treatment strategies, tailored to ROP severity, are necessary for optimal visual outcomes.